The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
CONTEXT THERAPEUTICS INC | COM | 21077P108 | 2,529,033 | 1,290,323 | SH | SOLE | N/A | 1,290,323 | 0 | 0 | ||
CORBUS PHARMACEUTICALS HLDGS | COM NEW | 21833P301 | 1,031,500 | 50,000 | SH | SOLE | N/A | 50,000 | 0 | 0 | ||
HERON THERAPEUTICS INC | COM | 427746102 | 13,903,621 | 6,986,744 | SH | SOLE | N/A | 6,986,744 | 0 | 0 | ||
INSPIREMD INC | COM | 45779A846 | 2,422,798 | 904,029 | SH | SOLE | N/A | 904,029 | 0 | 0 | ||
JASPER THERAPEUTICS INC | COM NEW | 471871202 | 4,614,620 | 245,328 | SH | OTR | N/A | 0 | 245,328 | 0 | ||
JASPER THERAPEUTICS INC | COM NEW | 471871202 | 22,355,685 | 1,188,500 | SH | SOLE | N/A | 1,188,500 | 0 | 0 | ||
KIORA PHARMACEUTICALS INC | COM | 49721T507 | 447,336 | 122,223 | SH | SOLE | N/A | 122,223 | 0 | 0 | ||
LIQUIDIA CORPORATION | COM NEW | 53635D202 | 3,000,000 | 300,000 | SH | SOLE | N/A | 300,000 | 0 | 0 | ||
OPTINOSE INC | COM | 68404V100 | 1,438,227 | 2,146,608 | SH | SOLE | N/A | 2,146,608 | 0 | 0 | ||
PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | 20,177,322 | 350,666 | SH | SOLE | N/A | 350,666 | 0 | 0 | ||
PROTARA THERAPEUTICS INC | COM STK | 74365U107 | 1,050,420 | 574,000 | SH | SOLE | N/A | 574,000 | 0 | 0 | ||
REZOLUTE INC | COM NEW | 76200L309 | 3,880,000 | 800,000 | SH | SOLE | N/A | 800,000 | 0 | 0 | ||
SCPHARMACEUTICALS INC | COM | 810648105 | 2,360,566 | 517,668 | SH | SOLE | N/A | 517,668 | 0 | 0 | ||
SKYE BIOSCIENCE INC | COM NEW | 83086J200 | 825,288 | 211,071 | SH | SOLE | N/A | 211,071 | 0 | 0 | ||
SPDR SER TR | S&P BIOTECH | 78464A870 | 14,820,000 | 150,000 | SH | Call | SOLE | N/A | 150,000 | 0 | 0 | |
TELA BIO INC | COM | 872381108 | 1,890,947 | 747,410 | SH | SOLE | N/A | 747,410 | 0 | 0 | ||
TENAX THERAPEUTICS INC | COM NEW | 88032L605 | 288,332 | 83,333 | SH | SOLE | N/A | 83,333 | 0 | 0 | ||
TOURMALINE BIO INC | COM | 89157D105 | 311,348 | 12,110 | SH | SOLE | N/A | 12,110 | 0 | 0 | ||
TOURMALINE BIO INC | COM | 89157D105 | 8,203,547 | 319,080 | SH | OTR | N/A | 0 | 319,080 | 0 | ||
ZEVRA THERAPEUTICS INC | COM NEW | 488445206 | 1,388,000 | 200,000 | SH | SOLE | N/A | 200,000 | 0 | 0 |